Perspective Therapeutics, Inc.

CATXAMEX • USD
ThemeHealthcare - Oncology›Radiopharmaceuticals & ADCs
3.01 USD
↗ 0.07 (2.45%)🟢PRE MARKET (AS OF 04:15 AM EDT)
🟢Market: OPEN

Perspective Therapeutics, Inc. (CATX) trades at $3.01 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, CATX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 6, 2026.

Open?$3.03
High?$3.03
Low?$3.01
Prev. Close?$2.94
Volume?N/A
Avg. Volume?1.8M
Bid / Ask
Bid?$2.85 × 100
Ask?$3.20 × 100
Spread?$0.35
Midpoint?$3.03
Valuation & Ratios
Market Cap?338.7M
Shares Out?114.0M
Float?94.7M
Float %?83.0%
P/E Ratio?N/A
P/B Ratio?0.97
EPS?-$0.97
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Themes
Healthcare - Oncology›Radiopharmaceuticals & ADCs
Employees
166
Market Cap
338.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.perspectivetherapeutics.com
Listed
2003-12-29
Address
2401 ELLIOTT AVENUE
SEATTLE, WA 98121
Phone: 206-676-0900
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
27
Momentum?
3
Short Sent.?
39
Piotroski F-Score?1/9Weak
Altman Z-Score?1.73Distress
Confidence?68%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?24.06%Squeeze Risk
Short Interest?22.8M
Days to Cover?10.0
Free Float94.7M
Avg Daily Volume2.3M
Settlement Date2026-07-15
Financial Health
Current Ratio?8.75Strong
Quick Ratio?8.75Strong
Cash Ratio?1.71Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.97CHEAP▾
P/S?
Peers
100
S&P
3
548.09HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.5CHEAP▾
EV/Sales?
Peers
100
S&P
3
463.36HIGH▾
Returns & Efficiency
ROE?
S&P
6
-32.0%WEAK▾
ROA?
S&P
3
-27.1%WEAK▾
Cash Flow & Enterprise
FCF?$-107447000
Enterprise Value?$286.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist